Redefining Intermediate-Stage HCC Treatment in the Era of Immune Therapies.

Brar, Gagandeep; Kesselman, Andrew; Malhotra, Anuj; Shah, Manish A

Brar, Gagandeep; Kesselman, Andrew; Malhotra, Anuj; Shah, Manish A.

Afiliação

Brar G; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/New-York Presbyterian, New York, NY.
Kesselman A; Division of Interventional Radiology, Department of Radiology, Weill Cornell Medicine/New-York Presbyterian, New York, NY.
Malhotra A; Division of Interventional Radiology, Department of Radiology, Weill Cornell Medicine/New-York Presbyterian, New York, NY.
Shah MA; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/New-York Presbyterian, New York, NY.

JCO Oncol Pract ; 18(1): 35-41, 2022 01.

Article em En | MEDLINE | ID: mdl-34255552

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Carcinoma Hepatocelular/terapia; Humanos; Neoplasias Hepáticas/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google